9R PHARMACEUTICALS
9R Pharmaceuticals is a small pharmaceutical company founded in 2018 with approximately 12 employees. Specific therapeutic focus areas, product pipeline, business model, and commercial activities cannot be determined from available sources.
- Company typePrivate
- Founded-
- Headquarters—
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
9R PHARMACEUTICALS firmographics
Firmographics- Name
- 9R PHARMACEUTICALS
- Website
- https://9rpharmaceuticals.com
- Company type
- Private
- Headcount range
- 11–50 employees
- Short description
- 9R Pharmaceuticals is a small pharmaceutical company founded in 2018 with approximately 12 employees. Specific therapeutic focus areas, product pipeline, business model, and commercial activities cannot be determined from available sources.
- Ownership category
- akta.pro rank
9R PHARMACEUTICALS industry classification
Industry- Product category
- Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Specialty Care Pharmaceuticals (HLAIAAAB)
Keywords
9R PHARMACEUTICALS business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain
9R PHARMACEUTICALS product offering
Product offeringCore offering
9R PHARMACEUTICALS is a pharmaceutical company founded in 2018. Based on the limited available information from the company website, it operates in the pharmaceutical sector with a small team of approximately 12 employees. The specific product lines, therapeutic areas, and detailed business activities are not disclosed in the available source material.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical Products
Companies that use 9R PHARMACEUTICALS
Customer profileIdeal customer profiles1 record
9R PHARMACEUTICALS technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
9R PHARMACEUTICALS competitors and assessment
Company assessmentEmerging players
- PharmaBlock Sciences: PharmaBlock is a publicly-traded specialty CDMO focused on building blocks, intermediates, and small-molecule API development. Comparable as a smaller, specialty-focused pharma services peer if 9R operates in development or specialty manufacturing.
Direct peers
- Novasep: Novasep is a privately-held CDMO providing API synthesis, chromatography, and specialty manufacturing services. Comparable as a private pharma services peer with overlapping capabilities in process development and small-molecule manufacturing.
- Seqens: Seqens is a privately-held CDMO offering API development, custom synthesis, and specialty manufacturing. Comparable as a mid-sized, privately-held pharma services peer with overlapping scope in small-molecule development and manufacturing.
- Hovione: Hovione is a privately-held CDMO specializing in small-molecule API development, particle engineering, and contract manufacturing. Comparable as a privately-held specialty pharma services peer with similar lean operational profile.
- Alcami Corporation: Alcami is a privately-held CDMO offering small-molecule API development, manufacturing, and analytical services. Comparable as a similarly-sized, privately-held pharma services peer if 9R operates in development or manufacturing services.
Broad incumbents
- Aenova Group: Aenova is a privately-held CDMO providing formulation development, manufacturing, and packaging for oral, topical, and sterile dosage forms. Comparable as a broad incumbent offering overlapping pharma services.
- PCI Pharma Services: PCI Pharma Services is a large private CDMO providing sterile fill-finish, manufacturing, and packaging services. Comparable as a broader incumbent offering overlapping pharma services, though at significantly greater scale than 9R.
- Curia Global (formerly AMRI): Curia is a privately-held CDMO offering API development, drug product manufacturing, and laboratory services. Comparable as a broad incumbent offering overlapping pharma development and manufacturing capabilities.
- Cambrex: Cambrex is a privately-held CDMO providing small-molecule API development and manufacturing across the full drug lifecycle. Comparable as a broad incumbent offering overlapping pharma services, though at significantly greater scale than 9R.
Others
- Eurofins Discovery Services: Eurofins Discovery Services offers contract research and laboratory services to the pharmaceutical industry. Comparable as an enabling, thematically-related services peer if 9R operates in pharma testing or development services.
Market position
Strengths2 records
Weaknesses3 records
Key risks6 records
Key highlights2 records
Customer concentration
9R PHARMACEUTICALS social profiles
Digital presence9R PHARMACEUTICALS financial estimates
Financial estimateRevenue estimate
Valuation estimate
9R PHARMACEUTICALS leadership team
Management profileNumber of profiles
9R PHARMACEUTICALS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
9R PHARMACEUTICALS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 9R PHARMACEUTICALS
What does 9R PHARMACEUTICALS do?
9R PHARMACEUTICALS is a pharmaceutical company founded in 2018. Based on the limited available information from the company website, it operates in the pharmaceutical sector with a small team of approximately 12 employees. The specific product lines, therapeutic areas, and detailed business activities are not disclosed in the available source material.
When was 9R PHARMACEUTICALS founded?
9R PHARMACEUTICALS was founded in -1. It employs 11 to 50 people.
Who are 9R PHARMACEUTICALS's main competitors?
PharmaBlock Sciences is listed as an emerging player. Direct peers are Novasep, Seqens, Hovione and Alcami Corporation. Broad incumbents are Aenova Group, PCI Pharma Services, Curia Global (formerly AMRI) and Cambrex. Eurofins Discovery Services is listed as an others.
Does 9R PHARMACEUTICALS have an API?
No public API is recorded for 9R PHARMACEUTICALS.
What industry is 9R PHARMACEUTICALS in?
9R PHARMACEUTICALS's product category is Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.